CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia
S. Dinakaran, H. Zhao, Y. Tang, Z. Wang, S. Ruiz, A. Nomura-Kitabayashi, L. Blanc, M. E. Faughnan, P. Marambaud
This study identifies CDK6-driven cell cycle acceleration in endothelial cells as a driver of arteriovenous malformations in HHT, suggesting CDK4/6 inhibitors as potential therapeutic options.
bioRxiv · Sep 15, 2023Cell Biology